Certification Rate
99%
Very high DOL cert
A DOL Labor Condition Application record spanning FY2023–2026. Review the filing volume, DOL certification record, and offered-wage context below.
Novato, CA NAICS: 325414
U.S. Department of Labor's OFLC discloses 104 Labor Condition Application filings naming BioMarin Pharmaceutical Inc. from FY2023 through FY2026, drawn directly from DOL's quarterly public disclosure releases. An LCA is the wage-and-working-conditions attestation an employer files with DOL before petitioning USCIS for an H-1B worker: it is a filing record, not a USCIS approval, a job offer, or a confirmed hire, and the count reflects filings, not people, since an employer sponsoring the same role at more than one worksite, or refiling across fiscal years, is counted once per filing. See filing history · Recent LCAs
Separate from the DOL filing record above, U.S. Citizenship and Immigration Services adjudicated 229 H-1B petitions naming BioMarin Pharmaceutical Inc. through FY2024, and approved nearly every one of them: 98.3% approved (225 approvals, 4 denials). A DOL certification is the labor-condition step filed before a petition; this USCIS figure is the actual adjudicated outcome, and the two rates commonly differ.
The verdict
BioMarin Pharmaceutical Inc. is listed in 104 DOL LCA filings, more filings than 98% of employer filers in this extract. DOL certified 99% of those LCAs; the median listed offered wage is $132,769. This is not a USCIS approval, hiring, or sponsorship ranking.
According to U.S. Department of Labor OFLC LCA disclosure files (FY2023–FY2026). Based in Novato, CA.
BioMarin Pharmaceutical Inc. LCA outcome mix
104DOL LCA filings on record
BioMarin Pharmaceutical Inc. vs all U.S. employer filers by LCA volume
Where this employer's disclosed Labor Condition Application count sits among every tracked employer filer (inventory signal, not a sponsorship ranking)
104 2421st of 122824 higher than 120,403 of 122,824 employer filers
Employer filers, banded by disclosed H-1B LCA filing count
Each bar is a band; taller bars hold more employer filers. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source U.S. Department of Labor OFLC · FY2023–FY2026
Derived from this employer's disclosed LCAs on file (FY2023–FY2026), title mix and worksite counties, not national boilerplate. LCA filings do not establish USCIS outcomes or confirmed hiring.
Offered-wage span on file: $60,757–$252,331 .
DOL LCA release change
BioMarin Pharmaceutical Inc. has filed 104 LCAs (more volume than 98% of U.S. employer filers in this extract). DOL certification: 99%. Worksites span 6 states , led by CA.
Only 104 LCAs on file for BioMarin Pharmaceutical Inc., and 76.9% land in MARIN, CA. Treat rates as descriptive of a small sample. DOL cert on file: 99%.
Certification Rate
99%
Very high DOL cert
Avg. Salary
$132,769
Above portal avg
Total Workers
104
Moderate worker count
BioMarin Pharmaceutical Inc. vs a peer vs the national average, from DOL LCA data.
37 completed-year filings in FY2023, 36 in FY2025. The scale spans up to twice the earlier year's count: the midpoint is unchanged and the endpoint is at least doubled.
Compensation range for H-1B positions at BioMarin Pharmaceutical Inc.
H-1B LCA filing trends from FY2023 to FY2026
FY2026 is partial on this extract. Chart shows completed fiscal years only (through FY2025).
Most frequently listed job titles at BioMarin Pharmaceutical Inc.
| Job Title | LCA filings | Avg. Salary |
|---|---|---|
| Scientist 1, Tech Ops | 3 | $111,374 |
| Scientist 1, Gene Therapy Research | 3 | $130,763 |
| VP, Head of Commercial Digital Strategy and Transformation | 2 | $235,934 |
| Technical Manager, External Quality | 2 | $120,078 |
| Sr. Research Associate 1, Tech Ops | 2 | $102,441 |
| Sr. Research Associate 1, Oligo. Protein Bioconjugate Prod. | 2 | $112,549 |
| Sr. Manager, US Health Economics and Value Demonstration | 2 | $101,046 |
| Sr. Manager, In Vivo Lead, Hematology Research | 2 | $130,135,335 |
| Sr. Manager, Commercial CFIT Solutions Delivery | 2 | $148,491 |
| Sr. Business Systems Analysis Manager | 2 | $183,368 |
| Senior Manager, Regulatory Affairs | 2 | $143,562 |
| Senior IM Business Systems Analyst Manager | 2 | $164,798 |
| Senior Analyst, QC Analytical Training and Validation | 2 | $76,461 |
| Scientist I, Pharmacology/Toxicology | 2 | $96,800 |
| Scientist 2, Neuroscience Research | 2 | $116,000 |
Where BioMarin Pharmaceutical Inc. places H-1B workers across the United States
Cross-state DOL neighbors for BioMarin Pharmaceutical Inc. - LCA filing-count and offered-wage axes, outside CA.
Nearest cross-state employer filers by LCA filing count (104 here; floor ≥10 LCA filings).
Cross-state employer filers with a comparable average listed offered wage ($132,769 here).
Disclaimer: Informational only, not professional advice.
ABS(total_petitions) peers first, then a LARGEST-distance pole and a stamp-branched drill, not a fixed Related strip. This page stamps MID-BOOK · CERT-CLEAN · WAGE-PREMIUM.
ABS(total_petitions) peer at 104 LCAs (Δ 0 heavier vs BioMarin Pharmaceutical Inc.); CERT-LOCK · WAGE-BELOW vs this page's MID-BOOK · CERT-CLEAN · WAGE-PREMIUM.
ABS(total_petitions) peer at 104 LCAs (Δ 0 heavier vs BioMarin Pharmaceutical Inc.); CERT-SOLID · WAGE-BELOW vs this page's MID-BOOK · CERT-CLEAN · WAGE-PREMIUM.
ABS(total_petitions) peer at 104 LCAs (Δ 0 heavier vs BioMarin Pharmaceutical Inc.); CERT-LOCK · WAGE-BELOW vs this page's MID-BOOK · CERT-CLEAN · WAGE-PREMIUM.
ABS(total_petitions) peer at 104 LCAs (Δ 0 heavier vs BioMarin Pharmaceutical Inc.); CERT-LOCK · WAGE-BELOW vs this page's MID-BOOK · CERT-CLEAN · WAGE-PREMIUM.
CA pole at 33,631 LCAs stamps MEGA-BOOK · CERT-CLEAN, farthest ABS(total_petitions) contrast from BioMarin Pharmaceutical Inc.'s MID-BOOK.
Open the CA state board after the ABS peers. BioMarin Pharmaceutical Inc. stamps MID-BOOK · CERT-CLEAN inside that worksite mix.
BioMarin Pharmaceutical Inc.'s WAGE-PREMIUM offered-wage posture needs occupation/state context, not a shared guide card.
What to do with this profile
Use the DOL LCA record for BioMarin Pharmaceutical Inc. to compare filing volume and offered wages, not USCIS outcomes.
DOL disclosure data only. Not legal advice, sponsorship guarantees, or visa eligibility.
Every figure on PlainVisa is rendered directly from federal source data, no number is typed in by an editor. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error. Data current as of 2026-09-09.